http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201800103-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd7b0bf0abd099c65d1733bb63d6e90f |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate | 2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7870b400e26c0220eccaaaa1b85d4175 |
publicationDate | 2018-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201800103-A |
titleOfInvention | Method for producing pharmaceutical composition having hemostatic function |
abstract | The invention discloses a method for manufacturing a pharmaceutical composition having a hemostatic function, comprising the steps of: firstly dissolving human albumin molecules in a buffer to obtain an albumin solution; and then, depending on the albumin solution Adding a surfactant, a crosslinking agent, and a solvent respectively to obtain an albumin suspension; then, adding fibrinogen to the albumin sphere suspension, wherein the fibrinogen is covalently bonded On the surface of the albumin sphere, a double layer of protein spherical particles is formed. The pharmaceutical composition prepared by the production method of the present invention is suitable for intravenous injection to treat a patient suffering from a platelet deficiency. |
priorityDate | 2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 299.